Skip to main content

Want a detailed portfolio tracker?

LENZ Therapeutics (LENZ) P/E (2021 - 2026)

LENZ Therapeutics (LENZ) P/E from Jun 30, 2021 to Jul 21, 2026. The TTM LENZ Therapeutics (LENZ) P/E is -1.44. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of LENZ Therapeutics (LENZ)

YearP/EChange
2026-1.44-74.90%
2025-5.75-62.55%
2024-15.35+614.53%
2023-2.15+6.19%
2022-2.02-85.51%
2021-13.96N/A

Comparison LENZ Therapeutics (LENZ) P/E with competitors

LENZ Therapeutics (LENZ) P/E is -1.44.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.12%
NBYStablecoin Development Corp0.00-100.30%
ENLVEnlivex Ltd0.07-105.18%
FGENFibroGen Inc0.24-116.63%
CHRSCoherus Biosciences Inc0.85-158.80%
FBIOFortress Biotech Inc0.95-165.77%
ORMPOramed Pharmaceuticals Inc1.50-204.16%
AGENAgenus Inc3.01-308.56%
INVAInnoviva Inc3.15-318.57%
VXRTVaxart Inc3.55-345.99%
CRMDCorMedix Inc3.63-351.44%
CVACCureVac N.V.4.45-408.07%
GLPGGalapagos NV4.86-436.71%
SRPTSarepta Therapeutics Inc4.88-438.32%
ABEOAbeona Therapeutics Inc5.39-473.34%
ABUSArbutus Biopharma Corp5.60-487.76%
ZVRAZevra Therapeutics Inc5.89-507.97%
SPROSpero Therapeutics Inc6.23-531.62%
CGENCompugen Ltd6.31-537.54%
RIGLRigel Pharmaceuticals6.87-576.22%
SLXNSilexion Therapeutics Corp7.30-605.60%
OMEROmeros Corporation9.26-741.61%
AUPHAurinia Pharmaceuticals Inc9.58-764.22%
PLXProtalix BioTherapeutics Inc10.89-854.72%
ACADAcadia Pharmaceuticals Inc11.73-912.76%
TBPHTheravance Biopharma Inc12.26-949.74%
ADMAAdma Biologics Inc12.42-960.55%
HRMYHarmony Biosciences Holdings Inc13.82-1057.71%
SABSSAB Biotherapeutics Inc14.14-1079.61%
NAGENiagen Bioscience Inc14.82-1126.86%
INCYIncyte Corp15.82-1196.47%
REGNRegeneron Pharmaceuticals Inc15.86-1198.83%
PBYIPuma Biotechnology Inc17.32-1299.94%
CPRXCatalyst Pharmaceuticals Inc17.44-1308.51%
EXELExelixis Inc17.54-1315.35%
TGTXTG Therapeutics Inc18.97-1414.31%
MDXGMimedx Group Inc20.55-1524.25%
XOMAXOMA Royalty Corp22.87-1685.21%
ARGXArgen X SE24.30-1783.85%
CTMXCytomX Therapeutics Inc24.82-1820.10%
XOMAOXOMA Royalty Corp25.34-1856.39%
HALOHalozyme Therapeutics Inc25.62-1875.72%
XOMAPXOMA Royalty Corp25.67-1878.93%
VRTXVertex Pharmaceuticals Inc27.99-2040.03%
RPRXRoyalty Pharma plc - Class A28.69-2088.04%
SLNOSoleno Therapeutics Inc29.02-2110.76%
ASNDAscendis Pharma A/S30.09-2184.92%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2727.29%
APLSApellis Pharmaceuticals Inc39.02-2804.16%
BMRNBiomarin Pharmaceutical Inc42.21-3025.27%
KRYSKrystal Biotech Inc45.34-3242.29%
ONCBeiGene Ltd69.54-4919.14%
PHARPharming Group N.V.75.03-5299.26%
TECHBio-Techne Corp101.96-7165.70%
VCELVericel Corp109.92-7717.53%
ALNYAlnylam Pharmaceuticals Inc117.96-8274.96%
GMABGenmab140.29-9822.12%
TLXTelix Pharmaceuticals Ltd162.15-11337.16%
CORTCorcept Therapeutics Inc212.86-14850.98%